Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
CoreRx, Inc., a CDMO with formulation, development and GMP manufacturing sites in Clearwater, Florida and San Rafael, California, is pleased to announce the appointment of Sitakant (S.K.) Chaudhury as Chief Financial Officer and as a member of CoreRx...
read more
Hovione, a provider of spray drying and particle engineering services, announced an exclusive license agreement for a preclinical ophthalmology program, JX08, with Ji Xing Pharmaceuticals Limited (JIXING).
read more
PCI Pharma Services (PCI), has announced a major expansion of capabilities and capacity in aseptic liquid fill-finish and sterile lyophilization technology, an important manufacturing process commonly used with injectable and biologic therapies, with...
read more
Taiwan-based contract development and manufacturing organization (CDMO) Bora Pharmaceuticals has announced the establishment of Bora Biologics Co., Ltd., a CDMO platform for biologics.
read more
ALSA Ventures, a London based European biotech investment firm, and Lonza, a global development and manufacturing partner to the pharma, biotech and nutrition industries, announced a framework collaboration agreement to help ALSA’s portfolio of pre-...
read more
Genovac, a contract research and manufacturing organization (CRO/CMO) that discovers, develops, and manufactures antibodies for therapeutic, diagnostic and research market segments, and ENPICOM, a bioinformatics software engineering company, ...
read more
Certified proof of sustainability in the areas of environment, labor, ethics and procurement is becoming increasingly important for companies and their suppliers. Almost half of the world’s leading pharmaceutical companies use the EcoVadis assessment...
read more
Bristol Myers Squibb and LOTTE Corporation announced that LOTTE has agreed to purchase Bristol Myers Squibb’s manufacturing facility in East Syracuse, New York.
read more
Crown Bioscience and Medical & Biological Laboratories (MBL), JSR Life Sciences companies, announced the formation of a joint venture, to further expand the provision of Crown Bioscience’s preclinical services to Japanese customers.
read more
CoreRx, Inc., an industry-leading CDMO with formulation development, analytical services and GMP manufacturing sites in Clearwater, Florida and San Rafael, California announces Michael Grass, Ph.D. has joined CoreRx as Senior Director of Product ...
read more
Crown Bioscience and Medical & Biological Laboratories (MBL), JSR Life Sciences companies announced the formation of a joint venture, to further expand the provision of Crown Bioscience’s preclinical services to Japanese customers.
read more
Societal CDMO, Inc. unveiled the company’s new “20/80 Second Source Technical Transfer” service model. This new CDMO offering is designed to provide pharmaceutical companies with a time- and cost-efficient preparedness strategy for mitigating supply ...
read more
Piramal Pharma Limited's Pharma Solutions business announced that a new active pharmaceutical ingredient (API) plant at the company's site in Aurora, Ontario, has come online and successfully completed its initial production runs.
read more
International Process Plants (IPP) announced its subsidiary Humber Industrials Ltd. has reached an agreement to purchase Novartis UK's 170-acre active pharmaceutical ingredient (API) manufacturing plant site and assets in Grimsby, UK.
read more
Eurofins Discovery announced the formation of its new Scientific Advisory Board (SAB). Company officials gathered renowned leaders from the pharmaceutical and biotechnology industries to gain strategic insights to address the unmet needs in drug ...
read more